Clinical trial transparency can build stakeholder trust and drive real value – but patient privacy must be protected. Read on to learn how.
Collaboration is a common thread at Privacy Analytics, running through all aspects of our culture and work. You feel it in our radically transparent quarterly town hall meetings...
When I think about what passion looks like at Privacy Analytics, it’s a quiet, underlying drive to innovate and push for a better world.
Just over a year ago, Health Canada stipulated that all clinical trials documents needed to make their way onto its designated portal.
Privacy Analytics is wholly committed to the global effort to respond to COVID-19.
How the CCPA is changing the legislative landscape
Compliance is important, and the first step for many transparency programs needing to satisfy EMA Policy 0070 and new Health Canada guidance.
Should sponsors integrate risk-based anonymization across both documents and structured individual patient data (S-IPD)?
Unstructured data, such as medical notes, pose unique challenges with regards to anonymization.
Health Canada has introduced new regulatory guidance for anonymizing clinical study reports.
Filter by Data Type
Categories